Log In
Print this Print this

64Cu-Liposomal PET Agent (MM-DX-929)

  Manage Alerts
Collapse Summary General Information
Company Merrimack Pharmaceuticals Inc.
DescriptionLiposomal PET imaging agent labeled with copper 64 (Cu-64)
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPreclinical
Standard IndicationCancer, Diagnostic
Indication DetailsPredict response to the liposomal chemotherapeutic MM-302 in patients with advanced HER2-positive breast cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today